Democritus University of Thrace
Alexandroupoli, Evros, 68100, Greece
NCT Number: NCT03024073
Patients who underwent presbyopic correction with bilateral bifocal intraocular lenses implantation are supposed to have sufficient uncorrected vision capacity for activities of daily living (ADLs) that require near vision acuity (NV), (ie. book reading). However, it is known that light intensity and temperature has a great impact on near vision capacity. Primary objective of this study is to identify the optimal task lighting conditions (in terms of light intensity and temperature) for ADLs that demand near vision acuity for a sample oa patients who underwent presbyopic correction with bilateral bifocal intraocular lenses implantation
Looking for future studies?
Notify Me45 year–65 year
All sexes
Observational
Alexandroupoli, Evros, 68100, Greece
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Phacoemulsification with bilateral bifocal lenses implantation
Time frame: 6 months
Near Vision Acuity
Time frame: 6 months
NVC score will be measured by the performance score in the following ADLs: a) cellular phone directory entry search, b) reading of message in a cellular phone, c) reading a medical prescription, d) reading a public phonebook
Democritus University of Thrace
Other
Assessment of Near Vision Capacity in Different Light Intensities and Temperatures in Patients Who Underwent Pseudophakic Presbyopic Correction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07723716
Eye Diseases, Presbyopia
Seoul, South Korea
View Trial DetailsNCT05646719
Eye Diseases, Presbyopia
Phoenix, Arizona, United States
View Trial DetailsNCT07076160
Eye Diseases, Presbyopia
Jacksonville, Florida, United States
View Trial DetailsNCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial Details